Table 3.
The relationships between the degree of hepatic steatosis and the clinical and biological parameters
|
Parameter |
Steatosis S1 (n=27) |
Steatosis S2 (n=27) |
Steatosis S3 (n=14) |
F ANOVA |
p ANOVA |
|
Gender (M/F) [n] |
9/18 |
14/13 |
2/12 |
– |
– |
|
Age [years] |
53.18±5.65 |
59.44±8.48 |
57.57±6.36 |
5.508 |
0.006 |
|
BMI [kg/m2] |
29.34±5.79 |
32.23±16.75 |
32.75±2.96 |
0.611 |
0.546 |
|
AST [U/L] |
37.92±2.12 |
45.66±8.48 |
49.78±31.81 |
3.259 |
0.045 |
|
ALT [U/L] |
47.33±0.7 |
54.07±28.28 |
79.5±21.21 |
11.991 |
<0.0001 |
|
Total cholesterol [mg/dL] |
198.14±31.81 |
198.55±9.89 |
215.5±26.87 |
2.783 |
0.069 |
|
Triglycerides [mg/dL] |
172±57.98 |
208±100.4 |
198±28.28 |
1.644 |
0.201 |
|
hs-CRP [mg/L] |
1.95±0.42 |
2.54±3.74 |
3.30±1.69 |
1.369 |
0.262 |
|
Fibrinogen [mg/dL] |
320.9±16.26 |
309.74±199.17 |
300.64±16.97 |
0.127 |
0.881 |
|
Leptin [ng/mL] |
10.52±3.39 |
16.10±8.62 |
16.75±2.98 |
7.64 |
0.001 |
|
Adiponectin [mg/L] |
8.88±2.26 |
7.37±4.66 |
5.29±3.39 |
4.611 |
0.013 |
|
Leptin/adiponectin ratio |
1.39±0.07 |
3.39±2.69 |
5.85±5.95 |
9.376 |
<0.001 |
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; BMI: Body mass index; F: Female; hs-CRP: High-sensitivity C-reactive protein; M: Male; n: No. of patients